Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9062485 | 0.90 | THRB (0.48) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL9224140 | 0.88 | THRB (0.47) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL5982433 | 0.86 | TSHR (0.61) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL6695792 | 0.84 | THRB (0.55) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL5981614 | 0.84 | TSHR (0.65) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL587661 | 0.82 | THRB (0.57) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL2453478 | 0.82 | THRB (0.57) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL3285653 | 0.82 | ALDH1A1 (0.44) | THRBTSHRALDH1A1TDP1HTT | |
| SCHEMBL10426403 | 0.82 | THRB (0.57) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL9312977 | 0.82 | THRB (0.57) | THRBTSHRALDH1A1TDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2517890-B1 | RESIN FILM FOR ULTRAVIOLET-CURABLE INKJET PRINTING, AND PRINTED MATTER RESULTING FROM PRINTING BEING APPLIED TO SAID FILM | YUPO CORP (JP) | 2019-05-15 | — | — | EP | disclosed |
| EP-1561791-B1 | New ink compositions for ink jet printing | AGFA GRAPHICS NV (BE) | 2016-03-16 | — | — | EP | disclosed |
| EP-1752463-B1 | NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX | SAN APRO LTD (JP) | 2013-07-17 | — | — | EP | disclosed |
| EP-2517890-A1 | RESIN FILM FOR ULTRAVIOLET-CURABLE INKJET PRINTING, AND PRINTED MATTER RESULTING FROM PRINTING BEING APPLIED TO SAID FILM | Yupo Corporation (JP) | 2012-10-31 | — | — | EP | disclosed |
| US-7709598-B2 | Fluorinated alkyl fluorophoshoric acid salts of onium and transition metal complex | SAN-APRO LIMITED (JP) | 2010-05-04 | — | — | US | disclosed |
| US-20070225458-A1 | Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex | SAN-APRO LIMITED (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1752463-A1 | NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX | San-Apro Limited (JP) | 2007-02-14 | — | — | EP | disclosed |
| EP-1561792-B1 | New ink compositions for ink jet printing | AGFA GEVAERT (BE) | 2006-08-30 | — | — | EP | disclosed |
| EP-0997508-B1 | New ink compositions for ink jet printing | AGFA GEVAERT (BE) | 2005-10-19 | — | — | EP | disclosed |
| EP-1561791-A1 | New ink compositions for ink jet printing | Agfa-Gevaert (BE) | 2005-08-10 | — | — | EP | disclosed |
| EP-1561792-A1 | New ink compositions for ink jet printing | Agfa-Gevaert (BE) | 2005-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225458-A1 | Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex | AS3MT, TTR, PFAS | THRB 1485/4885TSHR 753/4885ALDH1A1 3745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.